The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Budget Impact Analysis—Principles of Good Practice: Report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents
(1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-12_part_2-199806151-00003 · Cited by 5,209
Husereau, D., Drummond, M., Petrou, S., Carswell, C., Moher, D., Greenberg, D., Augustovski, F., Briggs, A. H., Mauskopf, J., & Loder, E. (2013) · Value in Health · doi:10.1016/j.jval.2013.02.002 · Cited by 1,998
Self-citationBriggs, A. H., Weinstein, M. C., Fenwick, E. A. L., Karnon, J., Sculpher, M. J., & Paltiel, A. D. (2012) · Medical Decision Making · doi:10.1177/0272989x12458348 · Cited by 887
Briggs, A. H., Weinstein, M. C., Fenwick, E. A. L., Karnon, J., Sculpher, M. J., & Paltiel, A. D. (2012) · Value in Health · doi:10.1016/j.jval.2012.04.014 · Cited by 823 · cited 2×
“Uncertainty of two types is relevant to a BIA: parameter uncertainty in the input values used and structural uncertainty introduced by the assumptions made in framing the BIA [24].”
BackgroundMethodEddy, D. M., Hollingworth, W., Caro, J. J., Tsevat, J., McDonald, K. M., & Wong, J. B. (2012) · Medical Decision Making · doi:10.1177/0272989x12454579 · Cited by 799
Caro, J. J., Briggs, A. H., Siebert, U., & Kuntz, K. M. (2012) · Value in Health · doi:10.1016/j.jval.2012.06.012 · Cited by 766
Mauskopf, J. A., Sullivan, S. D., Annemans, L., Caro, J., Mullins, C. D., Nuijten, M., Orlewska, E., Watkins, J., & Trueman, P. (2007) · Value in Health · doi:10.1111/j.1524-4733.2007.00187.x · Cited by 750
Self-citationEddy, D. M., Hollingworth, W., Caro, J. J., Tsevat, J., McDonald, K. M., & Wong, J. B. (2012) · Value in Health · doi:10.1016/j.jval.2012.04.012 · Cited by 466
Self-citationDeveloping Guidance for Budget Impact Analysis
Trueman, P., Drummond, M., & Hutton, J. (2001) · PharmacoEconomics · doi:10.2165/00019053-200119060-00001 · Cited by 228
Prevalence-Based Economic Evaluation
Mauskopf, J. (1998) · Value in Health · doi:10.1046/j.1524-4733.1998.140251.x · Cited by 79
Self-citationBudget impact analysis in economic evaluation: a proposal for a clearer definition
Garattini, L., & van de Vooren, K. (2011) · The European Journal of Health Economics · doi:10.1007/s10198-011-0348-5 · Cited by 74
Budget Impact Analysis of Thrombolysis for Stroke in Spain: A Discrete Event Simulation Model
Mar, J., Arrospide, A., & Comas, M. (2009) · Value in Health · doi:10.1111/j.1524-4733.2009.00655.x · Cited by 54
Practical issues in handling data input and uncertainty in a budget impact analysis
Nuijten, M. J. C., Mittendorf, T., & Persson, U. (2010) · The European Journal of Health Economics · doi:10.1007/s10198-010-0236-4 · Cited by 48
Marchetti, M., Caruggi, M., & Colombo, G. L. (2004) · Clinical Therapeutics · doi:10.1016/j.clinthera.2004.09.014 · Cited by 39
Calculation of Prevalence with Markov Models: Budget Impact Analysis of Thrombolysis for Stroke
Mar, J., Sainz-Ezkerra, M., & Miranda‐Serrano, E. (2008) · Medical Decision Making · doi:10.1177/0272989x07312720 · Cited by 31
Martin, E. G., Paltiel, A. D., Walensky, R. P., & Schackman, B. R. (2010) · Value in Health · doi:10.1111/j.1524-4733.2010.00763.x · Cited by 28
Smith, D. G., Cerulli, A., & Frech, F. H. (2005) · Clinical Therapeutics · doi:10.1016/j.clinthera.2005.06.014 · Cited by 27
Danese, M. D., Reyes, C. M., Northridge, K., Lubeck, D. P., Lin, C.-Y., & O’Connor, P. G. (2008) · Clinical Therapeutics · doi:10.1016/j.clinthera.2008.04.016 · Cited by 25
Jaime, J., Huybrechts, K. F., Xenakis, J. G., O’Brien, J. A., Rajagopalan, K., & Lee, K. S. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x148265 · Cited by 21
Self-citationBudget impact analysis of trastuzumab in early breast cancer: A hospital district perspective
Purmonen, T. T., Auvinen, P., & Martikainen, J. A. (2010) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462310000103 · Cited by 21
Newer Oral Anticoagulant Agents: A New Era in Medicine
Goel, R., & Srivathsan, K. S. (2012) · Current Cardiology Reviews · doi:10.2174/157340312801784934 · Cited by 17
Cited by
Husereau, D., Drummond, M., Augustovski, F., de Bekker-Grob, E., Briggs, A. H., Carswell, C., Caulley, L., Chaiyakunapruk, N., Greenberg, D., Loder, E., et al. (2022) · Value in Health · doi:10.1016/j.jval.2021.11.1351 · Cited by 1,095
Self-citationHusereau, D., Drummond, M., Augustovski, F., de Bekker-Grob, E., Briggs, A. H., Carswell, C., Caulley, L., Chaiyakunapruk, N., Greenberg, D., Loder, E., et al. (2022) · Value in Health · doi:10.1016/j.jval.2021.10.008 · Cited by 847
Self-citationEssential medicines for universal health coverage
Wirtz, V. J., Hogerzeil, H. V., Gray, A. L., Bigdeli, M., de Joncheere, C. P., Ewen, M. A., Gyansa-Lutterodt, M., Jing, S., Luiza, V. L., Mbindyo, R. M., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)31599-9 · Cited by 661
The new definition of health technology assessment: A milestone in international collaboration
O'Rourke, B., Oortwijn, W., Schuller, T., & the International Joint Task Group (2020) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462320000215 · Cited by 533
Husereau, D., Drummond, M., Augustovski, F., de Bekker-Grob, E., Briggs, A. H., Carswell, C., Caulley, L., Chaiyakunapruk, N., Greenberg, D., Loder, E., et al. (2022) · BMJ · doi:10.1136/bmj-2021-067975 · Cited by 472
Self-citation
Metadata
- Authors
- Sullivan, S. D., Mauskopf, J. A., Augustovski, F., Jaime Caro, J., Lee, K. M., Minchin, M., Orlewska, E., Penna, P., Rodriguez Barrios, J.-M., & Shau, W.-Y.
- Venue
- Value in Health
- Publisher
- Elsevier BV
- Published
- 2014-01
- Volume
- 17
- Issue
- 1
- Pages
- 5-14
- ISSN
- 1098-3015 (ISSN-L)
- OpenAlex
- W2119679249
- Cited by
- 1,172
- References
- 21
- FWCI
- 93.10
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.